Puma Biotechnology Inc
NASDAQ:PBYI

Watchlist Manager
Puma Biotechnology Inc Logo
Puma Biotechnology Inc
NASDAQ:PBYI
Watchlist
Price: 2.75 USD -1.08% Market Closed
Market Cap: 135m USD
Have any thoughts about
Puma Biotechnology Inc?
Write Note

Wall Street
Price Targets

PBYI Price Targets Summary
Puma Biotechnology Inc

Wall Street analysts forecast PBYI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PBYI is 4.42 USD with a low forecast of 2.02 USD and a high forecast of 7.35 USD.

Lowest
Price Target
2.02 USD
27% Downside
Average
Price Target
4.42 USD
61% Upside
Highest
Price Target
7.35 USD
167% Upside
Puma Biotechnology Inc Competitors:
Price Targets
OPK
OPKO Health Inc
162% Upside
ACLX
Arcellx Inc
57% Upside
RPTX
Repare Therapeutics Inc
866% Upside
XNCR
Xencor Inc
37% Upside
MRUS
Merus NV
112% Upside
688363
Bloomage Biotechnology Corp Ltd
4% Upside
GBIO
Generation Bio Co
500% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
32% Upside

Revenue
Forecast

Revenue Estimate
Puma Biotechnology Inc

The compound annual growth rate of Puma Biotechnology Inc's revenue for the next 4 years is -4%.

N/A
Past Growth
-4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Puma Biotechnology Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Puma Biotechnology Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PBYI's stock price target?
Price Target
4.42 USD

According to Wall Street analysts, the average 1-year price target for PBYI is 4.42 USD with a low forecast of 2.02 USD and a high forecast of 7.35 USD.

What is Puma Biotechnology Inc's Revenue forecast?
Projected CAGR
-4%

The compound annual growth rate of Puma Biotechnology Inc's revenue for the next 4 years is -4%.

Back to Top